By Abigail Townsend
Date: Monday 22 Sep 2025
(Sharecast News) - Pfizer Inc has agreed to buy biotech Metsera in multi-billion dollar deal, the US drugs giant confirmed on Monday, giving it a foothold in the booming weight-loss sector and sending shares in the start-up soaring.
Currency | US Dollars |
Share Price | $ 855.35 |
Change Today | $ 9.63 |
% Change | 1.14 % |
52 Week High | $932.06 |
52 Week Low | $625.65 |
Volume | 3,063,038 |
Shares Issued | 948.17m |
Market Cap | $811,017m |
Beta | 0.69 |
RiskGrade | 179 |
Time | Volume / Share Price |
15:59 | 100 @ $855.08 |
15:59 | 128 @ $855.08 |
15:59 | 200 @ $854.99 |
15:59 | 100 @ $854.24 |
15:59 | 100 @ $854.11 |
You are here: research